Murat Kalayoglu

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Murat Kalayoglu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Murat Kalayoglu:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cartesian Therapeutics, Inc. Director, 10%+ Owner Common Stock 4,555,260 $15,032,358 $3.3 02 Jan 2025 by trust
Cartesian Therapeutics, Inc. Director, 10%+ Owner Common Stock 508,977 $1,679,624 $3.3 02 Jan 2025 Direct
Cartesian Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 7,800 $6,162 $0.79 02 Jan 2025 Direct
Cartesian Therapeutics, Inc. Director, 10%+ Owner Series A Non-Voting Convertible Preferred Stock 56,402 11 Oct 2024 by trust

Insider Reports Filed by Murat Kalayoglu

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNAC Cartesian Therapeutics, Inc. 02 Jan 2025 2 $0 4 Director, 10%+ Owner 06 Jan 2025, 16:20
RNAC Cartesian Therapeutics, Inc. 11 Oct 2024 2 $0 4 Director, 10%+ Owner 15 Oct 2024, 16:53
RNAC Cartesian Therapeutics, Inc. 08 Apr 2024 4 $0 4 Director, 10%+ Owner 10 Apr 2024, 21:43
RNAC Cartesian Therapeutics, Inc. 02 Jan 2024 2 $0 4 Director, 10%+ Owner 04 Jan 2024, 17:04
SELB Cartesian Therapeutics, Inc. 13 Nov 2023 5 $154,906,737 4 Director, 10%+ Owner 15 Nov 2023, 16:41
SELB Cartesian Therapeutics, Inc. 13 Nov 2023 0 $0 3 Director, 10%+ Owner 15 Nov 2023, 16:37